we're watching

• How Congress will attempt to prevent a market collapse after ACA repeal • Impact on competition and costs from the outcomes of DOJ’s merger challenges • Rising prescription drug costs • Whether Medicaid and Medicare restructuring delivers new opportunities for health plans